Related Experiment Video

Updated: May 26, 2026

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

CYP2S1 is negatively regulated by corticosteroids in human cell lines

Ilona G Bebenek1, Parrisa Solaimani, Peter Bui

  • 1Molecular Toxicology Interdepartmental Program, Department of Pathology and Laboratory Medicine, and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA.

Toxicology Letters
|December 14, 2011
PubMed

Insights

Dexamethasone (DEX) represses the expression of Cytochrome P450 2S1 (CYP2S1), an enzyme involved in drug metabolism and cancer. This repression is mediated by the glucocorticoid receptor and requires histone deacetylase activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cytochrome P450s (CYPs) are crucial enzymes for metabolizing diverse compounds.
  • CYP2S1 exhibits unique metabolic capabilities and is expressed in various extrahepatic tissues.
  • Elevated CYP2S1 expression in epithelial tumors highlights its relevance in disease treatment.

Purpose of the Study:

  • To investigate the regulatory mechanisms of CYP2S1 expression.
  • To determine the effect of synthetic glucocorticoid receptor ligands on CYP2S1.
  • To elucidate the molecular pathways involved in CYP2S1 regulation.

Main Methods:

  • Dose-response studies using dexamethasone (DEX) to determine effective concentrations (ED50).
  • Time-course experiments to assess the kinetics of DEX-mediated repression.
  • Glucocorticoid receptor (GR) antagonist studies and histone deacetylase (HDAC) inhibition assays to explore the mechanism of action.

Main Results:

  • DEX effectively represses CYP2S1 expression with an ED50 between 1 nM and 3 nM.
  • Maximal repression of CYP2S1 by DEX is observed within 48 hours.
  • Repression of CYP2S1 by DEX is confirmed to be GR-dependent and requires HDAC activity.

Conclusions:

  • Dexamethasone and other corticosteroids significantly repress CYP2S1 expression.
  • The glucocorticoid receptor and histone deacetylase activity are essential mediators of this repression.
  • Understanding CYP2S1 regulation by glucocorticoids offers potential therapeutic strategies for diseases associated with its expression.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...